Real-world analysis reveals issues of adherence and discontinuation in ticagrelor therapy, suggesting enhanced patient education may improve long-term outcomes.
Real-world persistence with prolonged DAPT remains a challenge, often hindered by patient-driven discontinuation and adverse events. Enhanced patient education on therapy benefits and adherence may improve long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Giordano et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: